Conclusion:
To the best of our knowledge, this is the first report of
methemoglobinemia induced by a high dose of SMX/TMP in pediatric
patients occurring within three days which may indicate
methemoglobinemia due to SMX/TMP as a dose-related side effect.
Observation and rapid management are recommended.